These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 16020801)

  • 21. Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study.
    Haeberle H; Prohaska S; Martus P; Straub A; Zarbock A; Marx G; Zago M; Giera M; Koeppen M; Rosenberger P
    Trials; 2020 Mar; 21(1):242. PubMed ID: 32131881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High versus low positive end-expiratory pressure setting in patients receiving veno-venous extracorporeal membrane oxygenation support for severe acute respiratory distress syndrome: study protocol for the multicentre, randomised ExPress SAVER Trial.
    Nishikimi M; Ohshimo S; Hamaguchi J; Fujizuka K; Hagiwara Y; Anzai T; Ishii J; Ogata Y; Aokage T; Ikeda T; Yagi T; Suzuki G; Ishikura K; Katsuta K; Konno D; Hattori N; Nakamura T; Matsumura Y; Kasugai D; Kikuchi H; Iino T; Kai S; Hashimoto H; Yoshida T; Igarashi Y; Ogura T; Matsumura K; Shimizu K; Nakamura M; Ichiba S; Takahashi K; Shime N
    BMJ Open; 2023 Oct; 13(10):e072680. PubMed ID: 37852764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
    Dixon B; Smith RJ; Campbell DJ; Moran JL; Doig GS; Rechnitzer T; MacIsaac CM; Simpson N; van Haren FMP; Ghosh AN; Gupta S; Broadfield EJC; Crozier TME; French C; Santamaria JD;
    Lancet Respir Med; 2021 Apr; 9(4):360-372. PubMed ID: 33493448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized mechanical ventilation guided by ultrasound in patients with acute respiratory distress syndrome (PEGASUS): study protocol for an international randomized clinical trial.
    Sinnige JS; Smit MR; Ghose A; de Grooth HJ; Itenov TS; Ischaki E; Laffey J; Paulus F; Póvoa P; Pierrakos C; Pisani L; Roca O; Schultz MJ; Szuldrzynski K; Tuinman PR; Zimatore C; Bos LDJ;
    Trials; 2024 May; 25(1):308. PubMed ID: 38715118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individualized positive end-expiratory pressure setting in patients with severe acute respiratory distress syndrome supported with veno-venous extracorporeal membrane oxygenation.
    Yin C; Gao X; Cao C; Xu L; Lu X
    Perfusion; 2021 May; 36(4):374-381. PubMed ID: 32777988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation.
    Hodgson C; Goligher EC; Young ME; Keating JL; Holland AE; Romero L; Bradley SJ; Tuxen D
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD006667. PubMed ID: 27855477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial.
    McNamee JJ; Gillies MA; Barrett NA; Perkins GD; Tunnicliffe W; Young D; Bentley A; Harrison DA; Brodie D; Boyle AJ; Millar JE; Szakmany T; Bannard-Smith J; Tully RP; Agus A; McDowell C; Jackson C; McAuley DF;
    JAMA; 2021 Sep; 326(11):1013-1023. PubMed ID: 34463700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decision support system to evaluate ventilation in the acute respiratory distress syndrome (DeVENT study)-trial protocol.
    Patel B; Mumby S; Johnson N; Falaschetti E; Hansen J; Adcock I; McAuley D; Takata M; Karbing DS; Jabaudon M; Schellengowski P; Rees SE;
    Trials; 2022 Jan; 23(1):47. PubMed ID: 35039050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome.
    Santa Cruz R; Villarejo F; Irrazabal C; Ciapponi A
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD009098. PubMed ID: 33784416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study protocol: The Improving Care of Acute Lung Injury Patients (ICAP) study.
    Needham DM; Dennison CR; Dowdy DW; Mendez-Tellez PA; Ciesla N; Desai SV; Sevransky J; Shanholtz C; Scharfstein D; Herridge MS; Pronovost PJ
    Crit Care; 2006 Feb; 10(1):R9. PubMed ID: 16420652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung protective ventilation strategy for the acute respiratory distress syndrome.
    Petrucci N; De Feo C
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003844. PubMed ID: 23450544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demographics, Treatments, and Outcomes of Acute Respiratory Distress Syndrome: the Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis, and Trauma (FORECAST) Study.
    Fujishima S; Gando S; Saitoh D; Kushimoto S; Ogura H; Abe T; Shiraishi A; Mayumi T; Sasaki J; Kotani J; Takeyama N; Tsuruta R; Takuma K; Yamashita N; Shiraishi SI; Ikeda H; Shiino Y; Tarui T; Nakada TA; Hifumi T; Otomo Y; Okamoto K; Sakamoto Y; Hagiwara A; Masuno T; Ueyama M; Fujimi S; Yamakawa K; Umemura Y;
    Shock; 2020 May; 53(5):544-549. PubMed ID: 31348148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis.
    Mikkelsen ME; Shah CV; Meyer NJ; Gaieski DF; Lyon S; Miltiades AN; Goyal M; Fuchs BD; Bellamy SL; Christie JD
    Shock; 2013 Nov; 40(5):375-81. PubMed ID: 23903852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study.
    Neto AS; Barbas CSV; Simonis FD; Artigas-Raventós A; Canet J; Determann RM; Anstey J; Hedenstierna G; Hemmes SNT; Hermans G; Hiesmayr M; Hollmann MW; Jaber S; Martin-Loeches I; Mills GH; Pearse RM; Putensen C; Schmid W; Severgnini P; Smith R; Treschan TA; Tschernko EM; Melo MFV; Wrigge H; de Abreu MG; Pelosi P; Schultz MJ; ;
    Lancet Respir Med; 2016 Nov; 4(11):882-893. PubMed ID: 27717861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute respiratory distress syndrome (ARDS) treated successfully by veno-venous extracorporeal membrane oxygenation (ECMO) in a nearly drowned patient.
    Sonoo T; Ohshima K; Kobayashi H; Asada T; Hiruma T; Doi K; Gunshin M; Murakawa T; Anraku M; Nakajima S; Nakajima J; Yahagi N
    J Artif Organs; 2014 Sep; 17(3):281-4. PubMed ID: 24916482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological agents for adults with acute respiratory distress syndrome.
    Lewis SR; Pritchard MW; Thomas CM; Smith AF
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004477. PubMed ID: 31334568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower tidal volume at initiation of mechanical ventilation may reduce progression to acute respiratory distress syndrome: a systematic review.
    Fuller BM; Mohr NM; Drewry AM; Carpenter CR
    Crit Care; 2013 Jan; 17(1):R11. PubMed ID: 23331507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open-label randomized controlled trial of ultra-low tidal ventilation without extracorporeal circulation in patients with COVID-19 pneumonia and moderate to severe ARDS: study protocol for the VT4COVID trial.
    Richard JC; Yonis H; Bitker L; Roche S; Wallet F; Dupuis C; Serrier H; Argaud L; Thiery G; Delannoy B; Pommier C; Abraham P; Muller M; Aubrun F; Sigaud F; Rigault G; Joffredo E; Mezidi M; Terzi N; Rabilloud M
    Trials; 2021 Oct; 22(1):692. PubMed ID: 34635128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-frequency oscillatory ventilation versus conventional ventilation for acute respiratory distress syndrome.
    Sud S; Sud M; Friedrich JO; Wunsch H; Meade MO; Ferguson ND; Adhikari NK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004085. PubMed ID: 27043185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.